Hindered nucleoside analogs as antiflaviviridae agents

Articles in the same Issue

1. Predicting drug metabolism: Concepts and challenges
2. Prion protein as a target for therapeutic interventions
3. Structural basis for 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) receptor activation
4. Search for noncompetitive 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor (AMPAR) antagonists: Synthesis, pharmacological properties, and computational studies
5. Neuropeptide mimetics for pain management
6. New endomorphin analogs with mu-agonist and delta-antagonist properties
7. Spacer conformation in biologically active molecules
8. Discovery of new anti-inflammatory agents
9. NO donors: Focus on furoxan derivatives
10. Passive and catalytic antibodies and drug delivery
11. Virtual combinatorial chemistry and in silico screening: Efficient tools for lead structure discovery?
12. Development of modulators of multidrug resistance: A pharmacoinformatic approach
13. Hindered nucleoside analogs as antiflaviviridae agents
14. Solid- and solution-phase synthesis of bioactive dihydropyrimidines
15. Synthesis of naturally occurring o-heterocyclic compounds of biological activity
16. Glossary of terms used in toxicokinetics (IUPAC Recommendations 2003)